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In a cell, an enormous amount of energy is channelled into
the biogenesis of ribosomal RNAs (rRNAs). In a multistep
process involving a large variety of ribosomal and non-
ribosomal proteins, mature rRNAs are generated from a
long polycistronic precursor. Here, we show that the non-
ribosomal protein Nol9 is a polynucleotide 50-kinase that
sediments primarily with the pre-60S ribosomal particles
in HeLa nuclear extracts. Depletion of Nol9 leads to a
severe impairment of ribosome biogenesis. In particular,
the polynucleotide kinase activity of Nol9 is required for
efﬁcient generation of the 5.8S and 28S rRNAs from the
32S precursor. Upon Nol9 knockdown, we also observe a
speciﬁc maturation defect at the 50 end of the predominant
5.8S short-form rRNA (5.8SS), possibly due to the Nol9
requirement for 50430 exonucleolytic trimming. In con-
trast, the endonuclease-dependent generation of the
50-extended, minor 5.8S long-form rRNA (5.8SL) is largely
unaffected. This is the ﬁrst report of a nucleolar poly-
nucleotide kinase with a role in rRNA processing.
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Introduction
Ribosomal RNA (rRNA) maturation represents a dramatic
example of RNA processing, embracing a large number of
enzymatic activities, small nucleolar RNAs (snoRNAs) and
non-ribosomal proteins (Henras et al,2 0 0 8 ) .r R N Ap r o c e s s i n g
is best understood in the yeast Saccharomyces cerevisiae
(Venema and Tollervey, 1999). Analogous processing events
and the high conservation of the proteins involved suggest
substantial similarities among several organisms, yet individual
steps were shown to be variable (Gerbi and Borovjagin, 2004).
Three out of four human rRNAs, 18S, 5.8S and 28S,
are transcribed from one polycistronic transcription unit
(Gerbi and Borovjagin, 2004). In an ordered series of endo-
and exonucleolytic events, external and internal transcribed
spacers (ETS and ITS, respectively) are removed from the
primary transcript and the mature rRNAs liberated (Figure 1)
(Hadjiolova et al, 1993). Immediately after transcription,
external spacer sequences are degraded, generating ﬁrst 45S
and then 41S intermediates. A subsequent endonucleolytic
cleavage within ITS1 splits the 41S precursor into the 21S and
32S rRNAs. The 21S is further processed via the 18S-E
intermediate into the mature 18S rRNA, the RNA component
of the 40S small ribosomal subunit (SSU). Processing of 32S
is more complex, involving an elusive endonuclease activity
that cleaves within ITS2. Eventually, the mature 5.8S and 28S
rRNAs are liberated and assemble, together with the inde-
pendently transcribed and processed 5S rRNA, into the 60S
large ribosomal subunit (LSU). Two forms of 5.8S have been
described in yeast and mammals (Rubin, 1974; Bowman et al,
1983), a major short form (5.8SS) and a long, 50-extended
form (5.8SL).
Recent advances in large-scale mass spectrometry and high
throughput screens have revealed a multitude of proteins to
be involved in rRNA processing (Andersen et al, 2002; Scherl
et al, 2002; Boisvert et al, 2010), yet detailed studies on
their individual roles are missing and important enzymatic
activities are still elusive.
Our laboratory previously identiﬁed Clp1, an RNA 50-
kinase phosphorylating tRNA exons and siRNAs in vitro
(Weitzer and Martinez, 2007b). Clp1 was initially described
as a component of the mRNA 30 end formation and poly-
adenylation machinery (de Vries et al, 2000) and was later
also implicated in the splicing of precursor tRNAs as a
binding partner of the Sen endonuclease (de Vries et al,
2000; Paushkin et al, 2004). Bioinformatic analysis revealed
a family of proteins closely related to Clp1, the ‘Grc3/Nol9
family’ (Braglia et al, 2010), that contains Walker A and
Walker B motifs, both implicated in ATP/GTP binding
(Walker et al, 1982). Interestingly, human Nol9 was pre-
viously detected in proteomic analyses of the nucleolus
(Andersen et al, 2002; Scherl et al, 2002). Temperature
sensitive mutants of the yeast homologue of Nol9, Grc3,
showed an rRNA processing defect in a global screen for
non-coding RNA processing (Peng et al, 2003); yet, the role of
Grc3 is not clariﬁed.
Here, we identify Nol9 as a novel polynucleotide 50-kinase
that primarily co-sediments with nuclear pre-60S particles in
HeLa cells. We show that the kinase activity of Nol9 is required
for efﬁcient processing of the 32S precursor into 5.8S and 28S
rRNAs and present evidence for two different processing
pathways generating the two forms of 5.8S, similar to the
situation in yeast. This is the ﬁrst implication of a polynucleo-
tide kinase activity in the rRNA maturation pathway.
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Nol9 is a polynucleotide kinase
To determine whether Nol9 displays polynucleotide kinase
activity, we expressed and puriﬁed GST-tagged human Nol9
from insect cells (Figure 2A). Recombinant Nol9 phosphory-
lated single-stranded and double-stranded (ds) RNA and
DNA substrates with high efﬁciency (Figure 2B). In order to
analyse which terminus becomes phosphorylated, we incu-
bated GST-tagged Nol9 with dsRNA substrates displaying
either a phosphate or a hydroxyl group at the 50 or 30 ends
(Figure 2C). As a control, we used the well-studied T4
polynucleotide kinase (T4 PNK), which possesses kinase
activity towards the 50 end (Wang and Shuman, 2002). Nol9
was able to transfer a phosphate to 50 ends of dsRNAs, but
could not phosphorylate 30 termini, thus displaying the same
50-speciﬁcity as T4 PNK. We were also able to immunopurify
Nol9 RNA 50-kinase activity from nuclear extracts using
speciﬁc antisera (Figure 2D). We conclude that Nol9 is a 50
end-speciﬁc RNA/DNA kinase.
Nol9 co-sediments mainly with pre-60S rRNP particles
Nol9 was previously found in high-throughput proteomic
analyses of the human nucleolus (Andersen et al, 2002;
Scherl et al, 2002; Boisvert et al, 2010), the main site of
rRNA maturation (Boisvert et al, 2007). Already during
transcription, the nascent rRNA precursors are packaged
into precursor ribosomal particles (pre-rRNP), containing a
multitude of ribosomal and nucleolar proteins (Warner and
′ ′
Figure 1 The 18S, 5.8S and 28S rRNAs are organized into a single
polycistronic rDNA transcription unit, which also contains external
transcribed spacers (ETS) on the 50 and 30 ends and two internal
transcribed spacers (ITS). A series of endo- and exonucleolytic steps
are required for proper maturation of rRNAs via various intermedi-
ates. The mature 18S rRNA is eventually assembled into the 40S
small ribosomal subunit (SSU); 5.8S and 28S rRNAs together with
the independently transcribed and processed 5S rRNA are core
components of the 60S large ribosomal subunit (LSU). Two forms
of 5.8S are reported to co-exist; the major 5.8SS(hort) and the
50-extended 5.8SL(ong) form. Depicted are detectable intermediates
of the major rRNA processing pathway in HeLa cells (derived from
Hadjiolova et al, 1993; Rouquette et al, 2005). Boxes represent
rRNAs, triangles mark relevant endonucleolytic cleavage sites.
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Figure 2 Human Nol9 is a polynucleotide 50-kinase. (A) Coomassie blue-stained SDS–PAGE to monitor Nol9 puriﬁcation. GST-tagged wild-type
Nol9 was expressed in sf9 insect cells for 4 days. Cells were lysed by sonication and whole cell lysates separated by centrifugation into non-
soluble inclusion bodies and the soluble fraction, which was used as input in the puriﬁcation procedure. After incubation with the soluble
fractions, the glutathione beads were washed and subsequently the bound proteins eluted twice with glutathione. Only a minor fraction of the
protein stayed associated with the beads. Before being used in kinase assays, the two eluates were combined and concentrated. (B) Nol9
phosphorylates single (ss)- or double-stranded (ds) RNA and DNA substrates. Puriﬁed GST-tagged hNol9 was incubated with the indicated
substrates for the indicated time points. Phosphorylation was monitored by a mobility shift in electrophoresis. (C) Nol9 phosphorylates 50 ends
of dsRNA substrates. Puriﬁed GST-Nol9 was incubated with the indicated RNA substrates displaying either 50 and 30 hydroxyl or 50 phosphate
and 30 hydroxyl groups. Kinase activity was monitored over time. T4 polynucleotide kinase (PNK) was used as a control. Asterisk indicates
radioactive label within substrate RNA. (D) Endogenous Nol9 phosphorylates RNA substrates. 50-phosphorylation of dsRNA substrates after
immunoprecipitation (IP) from HeLa nuclear extracts using antisera against Nol9 or Clp1.
Nol9 in ribosomal RNA processing
K Heindl and J Martinez
The EMBO Journal VOL 29 | NO 24 | 2010 &2010 European Molecular Biology Organization 4162Soeiro, 1967; Granneman and Baserga, 2004). These com-
plexes allow for efﬁcient and accurate rRNA maturation and
also ensure quality control. Two major forms of pre-rRNP
particles are reported for HeLa nuclear fractions; the pre-40S
rRNP, containing the maturing 18S rRNA, and the pre-60S
rRNP particles, which include the 5.8S and 28S rRNAs
and their precursors (Vaughan et al, 1967; Warner and
Soeiro, 1967).
To investigate whether Nol9 associates with pre-rRNPs, we
separated nuclear extracts from HeLa cells on a 10–30%
sucrose density gradient and collected 18 fractions by down-
wards displacement. Each fraction was monitored by UV
spectrometry at 254nm to determine RNA content; yet,
fractions 14–18 could not be measured due to the high
sucrose concentration. Peaks comprising fractions 7–9 and
11–13 were observed, corresponding to the pre-40S and
pre-60S rRNP particles, respectively (Figure 3A). Every
fraction was tested for protein and RNA composition.
Immunoblotting revealed that Nol9 accumulated mainly in
fractions 12 and 13 (Figure 3B). Nucleophosmin/B23, which
co-localizes with ribosomal proteins of the 60S ribosomal
subunit in HeLa nucleoli (Maggi et al, 2008), was also over-
represented in these fractions together with the mature 28S
rRNA (Figure 3C) and 12S and 32S RNA, the precursors of
5.8S and 28S rRNAs, respectively (Figure 3D). RNA polymer-
ase II was used as a control, as it is not part of rRNP particle,
and sedimented at lower weight fractions (Figure 3B). A
signiﬁcant amount of Nol9 protein sedimented in fraction 8,
in which mature 18S rRNA accumulated (Figure 3B).
It appears that Nol9 is enriched to a certain extent within
both the pre-40S and pre-60S particles; however, Nol9 seems
to preferentially associate with the pre-rRNP containing 28S
and its precursor.
The composition of pre-rRNP particles is dependent on the
presence of RNA. Treating the nuclear extracts with RNase A
before centrifugation resulted in a different UV absorption
curve over the gradient, with no obvious peaks for the
pre-rRNP particles (data not shown). RNase A treatment
did not alter sedimentation of RNA polymerase II
(Figure 3E). Interestingly, Nol9 and B23 were largely shifted
from fractions around 12 to lighter fractions (Figure 3E). This
result shows that Nol9 associates with RNAs in nuclear
extracts and is possibly part of pre-rRNP particles.
Nol9 is required for rRNA processing
The above results together with the previous implication of
the yeast homologue of Nol9, Grc3, in rRNA maturation
(Peng et al, 2003) strongly suggested a role for Nol9 in the
processing of human rRNA. Therefore, we metabolically
labelled HeLa cells with
3H-methionine and chased rRNA
maturation with non-radioactive methionine. As precursor
rRNAs are heavily methylated early on, their processing
can be tracked over time. While 45S and 41S precursors are
rapidly processed in wild-type cells, the processing of 32S
precursors is slow (Figure 4A, panels I and II). RNAi-
mediated depletion (knockdown) of the RNA-kinase Clp1
did not interfere with the progress of rRNA maturation
(panel III). Strikingly, depleting the cells of Nol9 for 6 days
(91% knockdown efﬁciency, determined by qPCR, data not
shown) led to a drastic decrease of mature 28S levels after
240min of chase (panels IV and V), while the maturation of
18S was not affected. Additionally, processing of 45S and 41S
precursors was slightly delayed. This suggests a role for
Nol9 in the processing of rRNA, especially of the large
subunit 28S rRNA.
Nol9 functions in the processing of large subunit rRNAs
To further investigate processing defects, we conducted a
series of northern blots, probing for different processing
intermediates and products of the rRNA maturation path-
way (Figure 4B). Three distinct strategies were used to
A
B
C
D
E
Figure 3 Nol9 co-fractionates mainly with pre-60S particles.
(A) HeLa nuclear extracts were separated on a 10–30% sucrose
density gradient and divided into 18 fractions by downwards
displacement. UV absorption at 254nm of fractions 1–13 was
measured to follow RNA concentration and displayed in a graph.
All fractions were analysed for RNA and protein content.
(B) Fractions from (A) were loaded onto an SDS–PAGE to monitor
Nol9 fractionation by immunoblotting using afﬁnity-puriﬁed Nol9
antiserum. B23 and RNA polymerase II were used as controls.
(C) RNA was extracted from fractions in (A) and separated by
electrophoresis, transferred to a membrane and stained with methy-
lene blue to visualize 18S and 28S rRNAs. RNA from fraction 12 was
greatly lost during this procedure. (D) After methylene blue stain-
ing, the membrane from (C) was hybridized with probe NB39 (see
Figure 4B) to detect 32S and 12S processing intermediates. (E) Nol9
sedimentation is RNA dependent. Experiment was carried out as in
(B), but the nuclear extracts were treated with RNase A before
ultracentrifugation.
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of 70, 83 and 97% (Figure 4C, lanes 3, 4 and 5, respectively).
The effect on rRNA maturation correlated with the Nol9
knockdown efﬁcacy. Probes against the 5.8S (NB9) and 28S
(NB40) showed elevated levels of the 32S processing inter-
mediate and lower levels of all detectable downstream pro-
cessing products, including the 12S intermediate and the
mature 28S and 5.8S rRNAs (Figure 4C, panels NB9 and
NB40; Figure 4D, panel NB9). As observed in the pulse chase
experiment (Figure 4A), the early intermediates 45S and 41S
precursor rRNA accumulated in correlation with the knock-
down efﬁciency of Nol9 (Figure 4C, panel NB11). Maturation
of the 18S rRNA was not inﬂuenced by Nol9 knockdown
(Figure 4C, panel NB8). When we used probes against the U6
snRNA (data not shown) or the mitochondrial Glycine-tRNA
(Figure 4D, NB48) as loading controls for the northern blots,
5′ETS 3′ETS
5.8Ss
18S 5.8S 28S
ITS1 ITS2
A
B
C D
E
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loaded were always the same. We suggest that this is due to
an alteration of the overall composition of extracted RNA as a
consequence of Nol9 depletion, resulting from the vast
absence of the 28S and 5.8S rRNAs. As rRNAs make up the
majority of cellular RNAs, decreasing rRNA levels might
result in a relative enrichment of other RNA classes in total
RNA extracts. Acknowledging this theory, we normalized
the 5.8S levels observed in Figure 4D (NB9) to those of the
mitochondrial Glycine-tRNA (NB48). Nol9 knockdown de-
creased the absolute levels of 5.8SS to 0.08 (8%) and of 5.8SL
to 0.13 (13%) of mock-transfected cells.
The 5.8S and 28S rRNAs are core components of the large
60S ribosomal subunit, whereas the 18S is assembled into the
small 40S ribosomal subunit (Venema and Tollervey, 1999;
Fatica and Tollervey, 2002; Fromont-Racine et al, 2003). To
investigate whether the levels of 40S SSU, 60S LSU and 80S
ribosomes were imbalanced upon depletion of Nol9, we
carried out HeLa cytoplasmic extract sedimentation studies.
We observed a clear defect in 80S ribosome biogenesis in
HeLa cells depleted of Nol9 as a direct effect of the vast
absence of 60S ribosomal subunit (Figure 4E). This clearly
indicates a requirement of Nol9 for the maturation of the LSU
and hence the ribosome.
The polynucleotide kinase activity of Nol9 is required
for rRNA processing
To differentiate whether the kinase activity of Nol9 itself is
essential for rRNA maturation or Nol9 only serves as a
scaffold protein within a larger complex, we expressed and
puriﬁed kinase-inactive Nol9 mutants (Figure 5A). Nol9
contains Walker A and a Walker B motifs which are both
implicated in ATP/GTP binding (Walker et al, 1982).
Mutations within these domains often impair enzymatic
activity (Wang and Shuman, 2001). The Walker A motif
consists of the peptide stretch GxxxxGKS/T, which we altered
by exchanging the lysine or serine (positioned at amino-acid
312 and 313 in human Nol9, respectively) with an alanine
(referred to as K312A or S313A, respectively). These muta-
tions efﬁciently abolished kinase activity in recombinant
Nol9 conﬁrming that the Walker A motif is essential for
Nol9 activity (Figure 5B). To investigate the role of the kinase
activity of Nol9 in rRNA processing, we ﬁrst depleted Nol9
from HeLa cells and then expressed either wild-type or
Walker A mutant human Nol9. The 32S precursor levels
were monitored by northern blot and subsequently quantiﬁed
by signal intensity measurement. Upon Nol9 knockdown, the
levels of 32S were increased by a factor of 4.1 (Figure 5C,
panel NB39, and D). Whereas concurrent over-expression of
wild-type Nol9 diminished the elevated 32S levels to only 1.7,
both mutated forms of hNol9, K312A and S313A, could
mitigate the effect of the Nol9 knockdown on 32S levels
only slightly (Figure 5C, panel NB39, and D). The S313A
mutation seemed to be more severe than the K312A mutation
which showed a mild rescue effect on the levels of 32S
precursor rRNA. Equally, 41S and 45S precursor levels
could be efﬁciently decreased by over-expressing wild type
but not kinase-inactive Nol9 (Figure 5C, panel NB11).
Probing for 18S levels was used to monitor equal loading,
knowing that Nol9 does not alter its maturation. Wild-type
and mutant forms of Nol9 were expressed with equal efﬁ-
ciency as determined by qPCR (Figure 5E), excluding that the
above results were due to different expression levels.
Therefore, our data strongly suggest that the kinase activity
of Nol9 is required for efﬁcient rRNA processing.
Nol9 knockdown affects the ratio between short
and long 5.8S rRNA
In yeast, two alternate processing pathways are described to
generate the 50end of 5.8S rRNAs producing either the ‘short’
(‘5.8SS’) or the extended form of 5.8S rRNA bearing six
additional nucleotides on the 50 end (‘long’ or ‘5.8SL’)
(Schmitt and Clayton, 1993; Henry et al, 1994; Faber et al,
2006). In mammals, 50 heterogeneity of 5.8S rRNA was also
described (Khan and Maden, 1977; Bowman et al, 1983;
Smith et al, 1984). Aside the decrease of total 5.8S rRNA
upon knockdown of Nol9 (Figure 4D, panel NB9), we also
observed an alteration of the ratio between the short and the
long 5.8S rRNAs (Figure 6A). Whereas in wild-type HeLa
cells 5.8SS comprised 70% and 5.8SL only 30% of all mature
5.8S rRNAs, Nol9 knockdown reproducibly shifted this ratio
towards the long 5.8SL form, resulting in B55% 5.8SS versus
B45% 5.8SL. Primer extension analysis using two individual
primers near the 50 end of 5.8S (Figure 6B) conﬁrmed this
observation; the majority of transcripts terminated at the
predicted 50 end of 5.8S in wild-type RNA preparations,
while a smaller fraction of 50-extended transcript was
detected (Figure 6C and D). Although we could not predict
the exact sequence of the 50 extension from the primer
extension analysis, it still allowed us to conclude that 5.8SL
Figure 4 Depletion of Nol9 impairs ribosomal RNA processing. (A) Metabolic labelling of untreated (panel I) or mock-transfected HeLa cells
(panel II), or HeLa cells transfected with siRNAs targeting Clp1 (panel III) or Nol9 (panel IV). Cells were starved in methionine-free medium
followed by addition of
3H-methyl-methionine and chased in non-radioactive medium for the indicated time periods (in minutes). Panel V is
shown to compare all four backgrounds after chasing for 240min. (B) Illustration of the rRNA polycistronic transcript including the 50 and 30
external transcribed spacers (50ETS and 30ETS), the internal transcribed spacers 1 and 2 (ITS1 and ITS2) and the mature 18S, 5.8S and 28S
rRNAs. Magniﬁcation of the 5.8S rRNA shows the short 5.8SS (white box) and the additional 50 extension of the long 5.8SL form (dashed line).
Probes for northern blot are indicated by grey boxes (NB8, NB9, NB11, NB39 and NB40). (C) Nol9 depletion affects maturation of 28S, but not
18S rRNA. A total of 0.5mg total RNA containing wild-type levels of Nol9 mRNA (lanes 1 and 2), or obtained from different Nol9 knockdown
experiments (efﬁciencies determined by qPCR, data not shown; 70% knockdown efﬁciency, lane 3; 83%, lane 4; 97%, lane 5) were separated
by electrophoresis, transferred to a membrane and hybridized with the indicated probes. A longer exposure time was chosen for panel NB9 to
monitor 12S levels. The asterisk in panel NB11 indicates 50-elongated 32S intermediates. (D) Nol9 is required for maturation of the 5.8S rRNA.
A total of 1mg RNA from mock-transfected HeLa cells (lane 1) or cells transfected with siRNAs against Nol9 (lane 2) or Clp1 (lane 3)
were hybridized with a probe against 5.8S (NB9); mitochondrial tRNA
Gly (NB48) was used as control. Signal intensities were quantiﬁed,
normalized to lane 1 (wild type) and displayed beneath the blot. (E) Depletion of Nol9 results in a severe decrease of 60S and 80S ribosomes.
Ribosome proﬁles were obtained from HeLa cells transfected with a mock control or siRNAs against Nol9. Cytoplasmic extracts were separated
on a 10–45% sucrose density gradient. UV absorption along the gradient was measured.
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Nol9 knockdown decreased the short form, but did not alter
the relative levels of the long form of 5.8S (Figure 6D).
Altogether, we conclude that, similar to the situation in
yeast, in HeLa cells, two alternate pathways for the genera-
tion of the 50 end of 5.8S co-exist, resulting in either the short
or long 5.8S rRNA. Affecting the generation of the major short
form is not completely rescued by an increase of the levels of
the long form, suggesting that the pathway for 5.8SL cannot
complement the loss of the 5.8SS maturation machinery.
Therefore, the polynucleotide kinase Nol9 is primarily in-
volved in the generation of the major 5.8SS form.
Discussion
We report the involvement of Nol9, a novel polynucleotide
50-kinase, in the maturation of the 60S ribosomal subunit.
Nol9 is a potent RNA/DNA 50-kinase (Figure 2) that mainly
co-sediments with pre-60S rRNPs in nuclear extracts
(Figure 3). Absence of Nol9 decreases 5.8S and 28S rRNA
levels to a great extent and increases the levels of the 32S, 41S
and 45S precursors (Figure 4). Interestingly, the mere
presence of Nol9 in the cell is not enough to ensure efﬁcient
rRNA processing; only the wild-type, kinase-active form of
Nol9 is capable to overcome rRNA processing defects upon
prior depletion of Nol9 (Figure 5). Nol9 speciﬁcally impairs
maturation of the major 5.8SS form, but does not seem to be
involved in generating the minor 5.8SL form (Figure 6). As we
could not identify the direct substrate for Nol9 in rRNA
processing, we can only speculate on the role of the kinase
activity. The obvious block of 32S processing implies that
cleavage within ITS2, separating 5.8S and 28S, cannot occur.
This can be due to (1) a direct effect of Nol9 on the
endonuclease activity itself (Figure 7A, box 1) or (2) an
upstream quality control check that detects improperly com-
pleted 32S processing in ITS1 (Good et al, 1997) (Figure 7A,
box 2). Either option would lead to a transient accumulation
of 32S as well as the upstream precursors 41S and 45S
followed by premature degradation, as we observed upon
Nol9 knockdown (Figure 4A).
AB
C
D
E
Mock
Mock kd
Figure 5 The kinase activity of Nol9 is required for efﬁcient rRNA processing. (A) Coomassie blue-stained SDS–PAGE to monitor puriﬁcation
of the Nol9 mutants, as Figure 2A. (B) Nol9 Walker A mutations K312A and S313A abolish kinase activity. Equal amounts of puriﬁed GST-Nol9
(wild type or mutant) were incubated with double-stranded RNA substrates for indicated time points in minutes; o/n, over night; His-tagged
Clp1 was used as control. (C) HeLa cells were ﬁrst transfected with an empty vector (mock kd) or a short hairpin construct targeting the 30UTR
of Nol9 (Nol9 kd). In the second round of transfection, either an empty vector or a vector encoding wild-type Nol9, mutant version K312A or
S313A of Nol9 was co-transfected. RNAwas extracted, separated by electrophoresis, transferred to a membrane and hybridized using indicated
probes. (D) Signal intensities of 32S precursor from the above northern blots in (C), panel NB39, were quantiﬁed and displayed in a graph.
(E) qPCR analysis of Nol9 mRNA levels in the RNAextracts used in (C). Values were normalized to the mock knockdown/empty vector control.
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required for 32S processing (Figure 5C and D), Nol9 does
not only serve as a scaffolding protein, but actually contri-
butes to the rRNA maturation pathway with its kinase
activity. Interestingly, the RNA-kinase Clp1, a homologue of
Nol9, was found associated to the tRNA endonuclease com-
plex (Paushkin et al, 2004). In yeast, the 30 end of 18S is
generated by the endonuclease Nob1 (Pertschy et al, 2009),
which binds to the putative Walker A-type kinase Fap7
(Granneman et al, 2005). Although to date no deﬁnitive
role of a polynucleotide kinase within an endonucleolytic
event is identiﬁed, the recurring observations of complexes
containing both kinase and endonuclease activities are intri-
guing (Figure 7A, box 1).
rRNA processing follows a series of events, and only the
correct order assures proper maturation of the ribosomes. For
yeast it was shown that the accurate removal of spacer
sequences introduces conformational changes that allow
the pathway to proceed to the next step (Cote et al, 2002).
Most processing mutants only showed mild accumulations of
precursors due to rapid and complete degradation by the
exosome (Allmang et al, 2000), very similar to our observa-
tions for Nol9 depletion in HeLa cells. In yeast, the 50 end of
the 32S equivalent is mainly produced by the combined
action of an endonucleolytic cleavage event upstream and
subsequent exonucleolytic digestion by Rat1. A second, less
frequent pathway involves a single endonucleolytic cleavage
generating a 32S form containing a 50 extension of a few
nucleotides (Schmitt and Clayton, 1993; Chu et al, 1994;
Henry et al, 1994). In metazoans, the mechanism is assumed
to be similar (Tycowski et al, 1994). For HeLa cells, the
endonucleolytic cleavage site of the major pathway was
mapped between nucleotides 942 and 949 within ITS1,
B150 nucleotides upstream of the 32S precursor (Idol et al,
2007). Figure 4C, panel NB11, shows a blot hybridized to a
probe against the very 30 end of the spacer ITS1, visualizing
all 50-extended precursors of 32S RNA. A prominent smear
can be observed (indicated by an asterisk), which resembles
the 50-elongated 32S RNA after the endonucleolytic cleavage
of the main pathway in ITS1, but before complete exonucleo-
lytic degradation. Comparing lanes 1 (wild-type cells) and
5 (the most efﬁcient depletion of Nol9) by linear density
A
B
CD
Figure 6 Nol9 knockdown affects the ratio between 5.8SS and 5.8SL.( A) Signal intensities of 5.8SS and 5.8SL in Figure 4D were measured,
calculated ratios are depicted in a bar graph. (B) Genomic sequence of the ITS1-5.8S junction in the rDNA locus derived from NCBI
(HSU13369). Grey boxes depict location of primers used in primer extension. (C) A total of 1mg RNA from wild-type cells (‘wt’) or Nol9
knockdown cells (‘N’; identical to the RNA used in Figure 4C, lanes 1 and 5, respectively) were used in primer extension with the indicated
primer (NB82 or NB86). In parallel, sequencing reactions were performed using ddNTPs (A, ddATP; T, ddTTP; G, ddGTP; C, ddCTP) M, decade
marker with size indications on the left side. The sequencing results are depicted on the right side of both gels, asterisks indicate unreadable
results. According 5.8SS/L sequences as derived from the NCBI database (HSU13369) are illustrated inside the rectangles. (D) Signal intensities
of 5.8SS and 5.8SL from (C) were quantiﬁed and plotted against the y axis. Calculated ratios between the short and long forms are stated within
the columns.
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Figure 7 A model for the function of Nol9 in rRNA processing. (A) Possible roles of the polynucleotide kinase Nol9 in rRNA processing.
(1) Nol9 might act directly on the endonuclease cleaving within ITS2. (2) Nol9 together with an elusive phosphatase activity might regulate 50
end formation of 32S RNA by an exonuclease. (3) Nol9 might be required for snoRNA processing. Scissors indicate endonucleolytic cleavage
sites, the ‘pacman’ represents the exonuclease. RNAs are depicted in 50430 orientation. (B) Nol9 might function in the 50 end formation of
32S through 50430 degradation. Lanes 1 and 5 of the northern blot from Figure 4C, panel NB11, were analysed using the ImageQuant analysis
software by GE Healthcare. The signal intensities of the area depicted on the left side were gradually measured and illustrated in a
graph. Dashed lines mark the pixel position of the intensity peaks in the smear. (C) Over-expression of wild-type Nol9 can rescue the impaired
50 end formation of 32S rRNA upon prior Nol9 depletion. Lanes 5 to 8 of the northern blot from Figure 5C, panel NB11, were analysed as in (B).
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wild-type cells with peaks in the lower parts of the smear and
the 41S and 45S RNAs (Figure 7B). RNAi depletion of Nol9
not only increased the signal intensities of 41S and 45S RNAs,
but also shifted the intensity peak of the smear upwards,
indicating that the majority of the precursor is not efﬁciently
50 trimmed. Over-expression of wild-type Nol9 after Nol9
depletion eliminated this upwards shift and decreased the
signal intensities of 50-extended 32S precursors to almost
wild-type levels (Figure 7C). Kinase-inactive mutants could
not restore wild-type patterns, arguing for the importance of the
kinase activity of Nol9 in the formation of the 50 end of 32S. In
the course of rRNA processing, cleavage within ITS1 might
generate an entry point for the RNA-kinase Nol9, providing the
50 phosphate and thus a favourable substrate for the subsequent
50430 exonucleolytic activity (Stevens, 1980). Knocking down
Nol9 would impair this phosphorylation event, thereby block-
ing efﬁcient 50 end trimming to produce the actual 32S pre-
cursor and consequently resulting in an rRNA maturation defect
speciﬁcally of the large subunit rRNAs (Figure 7A, box 2).
Whereas in humans the endonuclease of the major path-
way cleaving within ITS1 is elusive, this process is well
characterized in yeast, in which the RNase MRP cleaves the
rRNA precursor at the corresponding A3 site, providing an
entry point for Rat1 (Schmitt and Clayton, 1993; Chu et al,
1994; Henry et al, 1994). Efforts to show this function for
metazoan MRP homologues have been unsuccessful so far. It
is worth noting that MRP belongs to the RNase P family and
generates 50 phosphorylated cleavage products (Reilly and
Schmitt, 1995). In case metazoan and yeast endonucleases
are similar, Nol9-kinase activity would not be required. As we
do not observe a distinct cleavage intermediate upon Nol9
knockdown, but a smear of exonucleolytic degradation inter-
mediates, our data could argue against a single entry point for
the kinase Nol9, but rather suggest constant phosphorylation
events after removal of each individual nucleotide
(Figure 7A, box 2). The following possibilities could support
our hypothesis; either the metazoan exonuclease generates 50
hydroxyl ends or a phosphatase activity continuously de-
phosphorylates the 50 ends and thus slows down 50430
degradation. The existence of a counteracting phosphatase
activity in human cells has been a matter of speculation
(Weitzer and Martinez, 2007a; Braglia et al, 2010), yet to
date, no such activity could be attributed to a known protein
in vivo or reconstituted in an in vitro system. However, it is
interesting to note that Grc3, the yeast homologue of Nol9,
was found in puriﬁcations of Rai1, an important partner and
enhancer of the 50430 exonuclease Rat1 (Sydorskyy et al,
2003). Depletion of Rai1 or Grc3 impairs Rat1-dependent
degradation of the 30 trailing transcript in RNA polymerase
I termination (El Hage et al, 2008; Kawauchi et al, 2008;
Braglia et al, 2010). In addition, we show that Nol9 depletion
mainly impairs maturation of the major 5.8SS form, but not of
5.8SL (Figure 6). In yeast, 5.8SL is generated by a distinct
endonucleolytic event, but does not involve the action of an
exonuclease (Faber et al, 2006). Our data present evidence
that two independent processing pathways also co-exist in
human cells generating either the short or long form of 5.8S.
Nol9 seems to be involved in the exonuclease-dependent
processing of 5.8SS rRNA.
Other possible substrates for Nol9 are the snoRNAs.
This class of RNAs guides rRNA modiﬁcations (Kiss-Laszlo
et al, 1996; Ganot et al, 1997; Ni et al, 1997) and can be
required for rRNA cleavage itself (Kass et al, 1990; Chu et al,
1994). More than 90% of human snoRNAs are encoded in the
introns of coding and non-protein-coding genes (Dieci et al,
2009). As for rRNAs, maturation of these snoRNAs involves
the concerted action of endo- and exonucleases (Filipowicz
and Pogacic, 2002). In yeast, Rat1 and Xrn1 are reported to
provide the 50430 exonuclease activity generating the 50 end
of intronic snoRNAs (Petfalski et al, 1998). Nol9 could be
involved in generating the 50 ends of snoRNAs in a similar
manner as described above for the 50 end formation of 32S
RNA (Figure 7A, box 3). As Nol9 depletion speciﬁcally blocks
generation of only the 5.8S and 28S rRNA, but does not
impair 18S maturation or RNA methylation as observed with
metabolic labelling (Figure 4A), it is unlikely that Nol9 is
involved in the general processing of snoRNAs.
In the light of the emerging evidence of new ‘un-tradi-
tional’ roles of the nucleolus (Olson et al, 2002; Gerbi et al,
2003), further studies could reveal additional functions for
Nol9. A growing number of RNPs and their components are
reported to localize to the nucleolus in some stages of their
life cycle, including not only SRP (Jacobson and Pederson,
1998) and RNase P (Jacobson et al, 1997), but also RNA
editing (Desterro et al, 2003), genome integrity (Kobayashi,
2008) and RNAviruses (Hiscox, 2007) were previously linked
to the nucleolus. Given that Nol9 can efﬁciently phosphor-
ylate RNA and DNA substrates, a future line of research will
be to ﬁnd endogenous substrates of Nol9. It will, therefore, be
interesting to reveal direct interacting partners of Nol9, which
could lead to new roles for the polynucleotide 50-kinase Nol9
in RNA metabolism.
Materials and methods
Expression and puriﬁcation of wild type and mutant Nol9
The open reading frame of human Nol9 (NM_024654) was cloned
into pDEST20 using the Gateway technique (Invitrogen) and
expressed in sf9 insect cells. After harvesting, the cells were lysed
in 100mM NaCl, 50mM Tris–Cl pH 8, 5mM MgCl2, 0.1mM AEBSF,
1mM DTT and sonicated. Puriﬁcation was performed using
Glutathione Sepharose 4B (GE Healthcare). Protein was eluted
from the beads twice with 20mM Glutathione pH 8, concentrated
on Vivaspin 500 columns (Sartorius) and dialysed against 30mM
Hepes pH 7.4, 5mM MgCl2, 100mM KCl, 10% Glycerol, 0.1mM
AEBSF before use in kinase assays. Site-speciﬁc mutations were
introduced using the QuikChange Site-directed mutagenesis kit
(Agilent Technologies) and primers hNol9_K312A_rev (GGTATCTAT
TAAATGTTGACGCTCCAACATCCTGGG) and hNol9_K312A_fw (CC
CAGGATGTTGGAGCGTCAACATTTAATAGATACC) or hNol9_S313A_
rev (GGTATCTATTAAATGTTGCCTTTCCAACATCCTGGG) and hNol9
_S313A_fw (CCCAGGATGTTGGAAAGGCAACATTTAATAGATACC).
In vitro kinase assay
Kinase assays were carried out as described in Weitzer and
Martinez (2007b) in the presence of 5mM ATP.
Immunoprecipitation of endogenous Nol9
Antisera were coupled to Protein A Sepharose 4FF (GE Healthcare)
and incubated with HeLa cell extracts for 2h at 41C. Kinase assays
were carried out directly on the beads. Antisera were produced by
Gramsch Laboratories, Germany and Clp1 antiserum 988 as
described in Weitzer and Martinez (2007b). Nol9 antiserum 1687/
1688 and 1689 were targeted against peptides EEAHKEKPYRRPKFC
and CITPRNRESHNKILR, respectively. Pre-immune serum was
taken from the rabbit before production of antiserum 1688.
Sucrose density studies
Ribosomal proﬁles were obtained as described in Strezoska et al
(2000) on a 10–45% sucrose gradient.
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on a 10–30% sucrose gradient. Gradients were fractionated using
downwards replacement and UV measurement was carried out
using NanoDrop spectrophotometer. Fractions were analysed
for RNA and protein content by northern blot and western blot,
respectively. Primary antibodies used were Nol9, afﬁnity-puriﬁed
antiserum 1687 (Gramsch Laboratories); Nucleophosmin/B23, B
0456 (Sigma) and Polymerase II antibody H14 (Covance). RNAse A
treatment was carried out incubating the nuclear extracts for 10min
at 301C with 100mg/ml RNAse A (Promega).
Cell culture, knockdown and transfection
HeLa cells were cultured as described in Weitzer and Martinez
(2007b). siRNA-directed knockdown was performed using Lipofec-
tamine 2000 reagent (Invitrogen) as recommended by the manu-
facturer and siRNAs against Clp1 (Dharmacon, L-019895-00) or
Nol9 (Dharmacon, L-019418-02 for 97% knockdown efﬁciency;
where indicated we used single siRNA targeting the 30 UTR of Nol9,
J-019418-18 for 70% knockdown efﬁciency). Optionally, we used
the pSUPER vector system (oligoengine) to produce a short hairpin
RNA targeting the 30 UTR of Nol9 using oligonucleotides
GATCCCCCCGATGCCCAAACCACTTTTTCAAGAGAAAAGTGGTTTG
GGCATCGGTTTTTA and AGCTTAAAAACCGATGCCCAAACCACTTT
TCTCTTGAAAAAGTGGTTTGGGCATCGGGG, as determined by
RNAxs (Tafer et al, 2008), resulting in 83% knockdown efﬁciency.
Knockdown was generally performed two consecutive times to
assure effectivity. Cells were transfected with the siRNA for 3 days,
split and re-transfected for another 3 days. Knockdown efﬁciency
was determined by qPCR using standard conditions and QIAGEN
QuantiTect Primer Assays (Nol9, QT00011305; GAPDH for normal-
ization, QT01192646). In the rescue experiments, the pSUPERvector
system was used for knockdown. In the second round of
transfection with the pSUPER vector, we co-transfected wild type
or mutant Nol9 cloned into the pcDNA-DEST53 Gateway vector
(Invitrogen).
Metabolic labelling
Cells were labelled with L-[methyl-
3H]-methionine as described in
Strezoska et al (2000).
Northern blot analysis
RNA was extracted from HeLa cells using TRIzol reagent (Invitro-
gen), transferred to a positively charged nylon membrane (Hybond
Nþ, GE Healthcare) in 20 SSC by capillary forces, UV-
cross-linked and incubated with Ambion Ultrahyb oligo buffer.
Hybridization to 50 (
32P)-phosphorylated oligonucleotides was
carried out over night at 621C, followed by consecutive washing
steps in 5% SDS/5 SSC, 1% SDS/1 SSC and 0.1% SDS/1 SSC.
Radioactive signals were analysed by phosphorimaging. For
analysis of the 5.8S rRNA, total RNA was separated on an 8% urea
polyacrylamide gel (PAGE) (SequaGel system, National Diagnos-
tics) and transferred to a nylon membrane in 0.5  TBE with
300mA for 2h. Probes used: NB8 CCGGCCGTGCGTACTTAGACATG
CATGGC,
NB9 CCGGGGCCGCAAGTGCGTTCGAAGTGTCG,
NB11 GGTCGATTTGGCGAGGGCGCTCCCGACG,
NB39 GGCGATTGATCGGCAAGCGACGCTCAGAC,
NB40 CTCCTTGGTCCGTGTTTCAAGACGGGTCGGG,
NB48 TACTCTTTTTTGAATGTTGTCAAAACTAGTTAATTGGAAG
TTAACGGTACTATTTATACTAAAAGAGT,
For quantiﬁcation of signal intensities in northern blot analyses
the ImageQuant analysis software by GE Healthcare was used.
Primer extension analyses
Primer extension analysis was adapted from Beltrame and Tollervey
(1992). A total of 1mg RNA from wild-type or Nol9 knockdown
cells were shortly incubated with 0.5pmoles primer (NB82 CTAG
CTGCGTTCTTCATCGACG or NB86 CGCACGAGCCGAGTGATC) at
851C for denaturation. Consequently, primer extension was per-
formed with the Invitrogen Superscript III system for 50min at 501C
in the presence of 1mM dNTPs. For the sequencing reaction, the
indicated ddNTPs (A, ddATP; T, ddTTP; G, ddGTP; C, ddCTP) were
added to the primer extension reaction at a ﬁnal concentration
of 0.25mM. Reactions were loaded on an 8% urea PAGE and
visualized by phosphorimaging.
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